Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Inhaled corticosteroids for abnormal pulmonary function in children with a history of chronic lung disease of infancy: Study protocol [ISRCTN55153521]
BMC Pulmonary Medicine, Volume 5, Article 6, Year 2005
Notification
URL copied to clipboard!
Description
Background: There is considerable evidence from the literature that children with chronic lung disease of infancy (CLD) have abnormal pulmonary function in childhood and this could have an impact on their life quality and overall health. There are similarities between CLD and asthma, and corticosteroids are the mainstay treatment for asthma. Many physicians use inhaled corticosteroids in children with CLD with no evidence. Therefore we wish to conduct a randomized double-blinded placebo controlled trial to test for the role of inhaled corticosteroids in children aged from3 to 9 years with a history of CLD. Our primary hypothesis will be that inhaled corticosteroids are beneficial in children with CLD. Methods: Our primary hypothesis is that using inhaled steroids; Beclomethasone Dipropionate (QVAR) 100 mcg 2 puffs 2 times a day for 6 weeks will improve the respiratory system resistance and the quality of life in children with CLD. Discussion: We propose that Beclomethasone Dipropionate (QVAR) will affect the pulmonary function after 6 weeks of treatment. In summary we think that our study will highlight knowledge on whether the use of inhaled steroids is clinically effective for CLD. © 2005 Alotaibi et al; licensee BioMed Central Ltd.
Authors & Co-Authors
Alotaibi, Saad
Kuwait, Safat
Farwania Hospital
Johnson, David
Canada, Calgary
University of Calgary
Montegomery, Mark
Canada, Calgary
University of Calgary
Sauvé, Reg S.
Canada, Calgary
University of Calgary
Spier, Sheldon
Canada, Calgary
University of Calgary
Statistics
Citations: 5
Authors: 5
Affiliations: 2
Identifiers
Doi:
10.1186/1471-2466-5-6
ISSN:
14712466
e-ISSN:
14712466
Research Areas
Disability
Maternal And Child Health